Key result
Cardiomyocyte mitochondrial BK channels are required for cardioprotection from ischemic postconditioning and PDE5 inhibitors.
Why the study?
It is unclear whether cardioprotection afforded by cardiomyocyte cGMP in vivo requires mitochondrial BK channels.
Cardiomyocyte BK channels and NO-GC are essential for cardioprotection against ischemia/reperfusion injury elicited by ischemic conditioning or PDE5 inhibitors.
BK channel-targeted cardioprotection should not yet inform clinical practice; leaves open therapeutic relevance pending human translation studies.
By studying hearts obtained from global BK-null mice (BK-KO) in an ex vivo Langendorff perfusion setup we and others previously found evidence for mitochondrial BK channels (mitoBKs) in cardiomyocytes as infarct-limiting factors [ 1 , 2 ]. It is well established that canonical BK channels usually present at the plasma membrane of cells are directly stimulated by the cyclic guanosine-3',5'-monophosphate (cGMP)/cGMP-dependent protein kinase type I pathway; however, it is unclear whether cardioprotection afforded by cardiomyocyte (CM) cGMP in vivo requires mitoBK. Using the Cre/loxP recombination system we generated animals with a CM-restricted deletion of BK channels (CMBK-KO) [ 3 ] and of nitric oxide (NO)-sensitive guanylyl cyclases (CMsGC-KO) [ 4 ]. The susceptibility of the conditional mutants to ischemia/reperfusion (I/R) injury was compared to age- and litter-matched controls (CMBK-CTR and CMsGC-CTR) as well as to global BK-KO and BK wild-type (BK-WT) mice. An open chest in situ model of myocardial infarction was applied to determine differences in infarct size at baseline and upon ischemic pre-/postconditioning (iPre/iPost) or pharmacological interventions using either the BK blocker paxilline, the BK opener NS11021 or the phosphodiesterase 5 (PDE5) inhibitors sildenafil and tadalafil, which are cardioprotective agents that should signal via increasing cGMP [ 5 , 6 ]. Baseline infarct size of CMsGC-KOs did not differ from that of CMsGC-CTRs, however, 30 min of ischemia followed by 120 min of reperfusion provoked significantly more cardiac damage in global BK-KO and CMBK-KO mice than in age- and litter-matched BK-WTs and CMBK-CTRs, respectively. The BK blocker paxilline (applied 5 min after the onset of ischemia) did not affect the response to I/R of CMBK-KO hearts, whereas in hearts from CMBK-CTR mice we observed an increase in the cardiac damage. With the BK opener NS11021 (5 min before reperfusion) we observed a more drastic decrease in the infarct size in hearts from CMBK-CTR than in CMBK-KO mice. As expected, short repetitive episodes of ischemia applied directly after infarction (iPost) significantly reduced the myocardial damage in all WT/CTR hearts, whereas protection afforded by iPost was less pronounced in the absence of mitoBK channels and completely abolished in hearts lacking CM NO-sGC. Interestingly, cardioprotection elicited either by an intra-atrial injection of sildenafil (5 min before reperfusion) or by an i.p. injection of tadalafil (60 min before the ischemic insult) also seems to require mitoBK and NO-GC in the CM. In summary, the presented findings demonstrate that the lack of CM BK channels renders the heart more susceptible to I/R injury. Cardioprotection elicited by the BK opener NS11021 suggests that BK channels may be promising drug targets that interfere with the causes and/or consequences of myocardial ischemia. Interestingly, both CM NO-GC and BK are important to allow the protective signaling events triggered either by short, repetitive episodes of ischemia or by agents targeting PDE5. Further studies are needed to elucidate whether cardioprotection via NO-GC and BK are linked by a common cGMP pathway in the CM itself.
No takes yet. Share an insight, caveat, or question.
Frankenreiter et al. (2015) studied Myocardial ischemia/reperfusion injury. Ischemic pre-/postconditioning and pharmacological interventions (NS11021, sildenafil, tadalafil) vs. Wild-type and litter-matched control mice was evaluated on Infarct size. The lack of cardiomyocyte BK channels renders the heart more susceptible to ischemia/reperfusion injury, and cardioprotection elicited by ischemic postconditioning or PDE5 inhibitors requires mitochondrial BK channels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: